New disease-modifying antirheumatic drug 2...

Journal of Laboratory and Clinical Medicine 2001 Vol. 138; Iss. 1

New disease-modifying antirheumatic drug 2 acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298) selectively augments activation-induced T cell death

Satoshi Urayama, Atsushi Kawakami, Tomoki Nakashima, Satoshi Yamasaki, Ayumi Hida, Hiroaki Ida, Makoto Kamachi, Hideki Nakamura, Tomoki Origuchi, Kiyoshi Migita, Yojiro Kawabe, Katsumi Eguchi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
138
Year:
2001
Language:
english
Pages:
7
DOI:
10.1067/mlc.2001.115938
File:
PDF, 210 KB
english, 2001
Conversion to is in progress
Conversion to is failed